Lowor normal levels of calcitonin in the setting of metastatic disease is a poorprognostic marker which may indicate dedifferentiation into poorly differentiateddisease, an entity characteristically more aggressive and associated with worse outcomes.19 The gene discussed is CALCA; the disease is metastatic neoplasm.